
In first open-label phase 3 data from the ADEPT program, KarXT cut hallucination and delusion scores in Alzheimer disease psychosis, with no new safety signals.
resident's corner blogger
Dr Forman was a resident in the department of psychiatry and behavioral sciences at Montefiore Medical Center in the Bronx, New York. He is currently a Fellow in the division of psychiatry and the law at Albert Einstein College of Medicine.




